UnknownPhase 4

The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis

Israel75 participantsStarted 2017-04-28

Plain-language summary

The study aims to investigate the effect of Permethrin 5% treatment on Signs and symptoms of Demodex-blepharitis in comparison to Synthomycine 5% and Fucithalmic (fusidic acid 1%) .

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Adult (Age ≥18Y) individuals clinically diagnosed with Demodex- blepharitis. Exclusion Criteria: \- Known sensitivity to all study medications or components. Pregnant women and individuals deemed unfit to provide informed consent. Systemic steroid use.

What they're measuring

Decrease in demodex infestation in group A (permethrin 5%).

Timeframe: 2 months

Improvement in symptoms and complaints in group A.

Timeframe: 2 months

Trial details

NCT IDNCT03105505

SponsorBarzilai Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-09

View on ClinicalTrials.gov More Inflammation of the Eyelids trials